• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 26, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Mountain gorillas have herpes virus similar to that found in humans

Bioengineer.org by Bioengineer.org
January 19, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Courtesy Tierra Smiley Evans/UC Davis

Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific Reports.

Epstein Barr virus, or EBV, infects more than 90 percent of the human population, typically without major health consequences or symptoms. It can be challenging, however, for people with HIV/AIDS and suppressed immune systems, leading to certain forms of cancer. The Epstein-Barr virus is also one of the major causes of mononucleosis, commonly called the "kissing disease."

The study found that the mountain gorillas, a critically endangered species, have their own version of this herpes virus – a specific strain of lymphocryptovirus 1, or GbbLCV-1.

VIRUS WIDESPREAD, BUT FEW SYMPTOMS

For the study, UC Davis researchers from Gorilla Doctors collected plants chewed by wild mountain gorillas in Rwanda and Uganda and analyzed the saliva left on the plants. This non-invasive, oral sampling technique showed that the virus is widespread, infecting 52 percent of infant gorillas studied. That is a similar rate to what is found in human infants in less developed countries.

The researchers say that the virus carries little health risk for otherwise healthy mountain gorillas and, like EBV, is typically dormant in their bodies. None of the live gorillas studied showed symptoms of having it.

However, the research team found that some infant gorillas who died of natural causes and were necropsied had "pulmonary reactive lymphoid hyperplasia," a condition seen in human infants and young children with HIV/AIDS who become infected with EBV.

The findings could provide valuable information for human disease and have conservation implications for the gorillas.

"Viruses can behave similarly in different species," said lead author Tierra Smiley Evans, a post-doctoral researcher with the UC Davis One Health Institute in the School of Veterinary Medicine. "Learning about how gorillas react to this virus in their natural setting may help us have a better understanding of how Epstein-Barr virus affects human infants."

Mountain gorillas are one of humans' closest genetic relatives. Among the great apes, they are among the most studied. Veterinarians from the Gorilla Doctors, a partnership between the UC Davis Wildlife Health Institute and the nonprofit Mountain Gorilla Veterinary Project, treat injured wild mountain gorillas and can continue to study this condition in the future.

###

Additional co-authoring institutions include the UC Davis Center for Comparative Medicine, One Health Approach for Conservation – Gorilla Health Rwanda, and the Rwanda Development Board in Kigali, Rwanda.

The study was funded by a William J. Fulbright Fellowship and the USAID Emerging Pandemic Threats PREDICT project.

Media Contact

Kat Kerlin
[email protected]
530-750-9195
@ucdavisnews

http://www.ucdavis.edu

Share12Tweet7Share2ShareShareShare1

Related Posts

New Drug Aims to Combat Neuroinflammation in Brain Injuries

November 26, 2025

Plastic Hepatocyte States Hinder Liver Cancer Growth

November 26, 2025

Oral Toxicity of Small Polyamide Microplastics Studied

November 26, 2025

Lysosomal Acidity Triggers Eosinophils in Allergy

November 26, 2025
Please login to join discussion

POPULAR NEWS

  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    203 shares
    Share 81 Tweet 51
  • Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    119 shares
    Share 48 Tweet 30
  • Neurological Impacts of COVID and MIS-C in Children

    94 shares
    Share 38 Tweet 24
  • Scientists Create Fast, Scalable In Planta Directed Evolution Platform

    100 shares
    Share 40 Tweet 25

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New Drug Aims to Combat Neuroinflammation in Brain Injuries

Plastic Hepatocyte States Hinder Liver Cancer Growth

Oral Toxicity of Small Polyamide Microplastics Studied

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.